Fidelity Investments’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.3M | Sell |
5,584,858
-1,261,984
| -18% | -$6.39M | ﹤0.01% | 1584 |
|
|
2025
Q1 | $36.2M | Sell |
6,846,842
-225,339
| -3% | -$1.19M | ﹤0.01% | 1480 |
|
|
2024
Q4 | $47.8M | Sell |
7,072,181
-1,291,349
| -15% | -$8.73M | ﹤0.01% | 1404 |
|
|
2024
Q3 | $55.1M | Buy |
8,363,530
+170,810
| +2% | +$1.13M | ﹤0.01% | 1335 |
|
|
2024
Q2 | $61.4M | Sell |
8,192,720
-1,068,151
| -12% | -$8.01M | ﹤0.01% | 1234 |
|
|
2024
Q1 | $92.3M | Sell |
9,260,871
-1,636,416
| -15% | -$16.3M | 0.01% | 1089 |
|
|
2023
Q4 | $107M | Buy |
10,897,287
+207,755
| +2% | +$2.05M | 0.01% | 981 |
|
|
2023
Q3 | $81.8M | Buy |
10,689,532
+6,129,935
| +134% | +$46.9M | 0.01% | 1057 |
|
|
2023
Q2 | $34.1M | Sell |
4,559,597
-195,864
| -4% | -$1.46M | ﹤0.01% | 1420 |
|
|
2023
Q1 | $31.7M | Buy |
4,755,461
+289,746
| +6% | +$1.93M | ﹤0.01% | 1421 |
|
|
2022
Q4 | $34.4M | Buy |
4,465,715
+214,551
| +5% | +$1.65M | ﹤0.01% | 1405 |
|
|
2022
Q3 | $45.2M | Buy |
4,251,164
+1,415,312
| +50% | +$15.1M | ﹤0.01% | 1279 |
|
|
2022
Q2 | $23.1M | Buy |
2,835,852
+690,213
| +32% | +$5.62M | ﹤0.01% | 1589 |
|
|
2022
Q1 | $15.4M | Buy |
2,145,639
+615,413
| +40% | +$4.41M | ﹤0.01% | 1915 |
|
|
2021
Q4 | $26.2M | Sell |
1,530,226
-429,737
| -22% | -$7.36M | ﹤0.01% | 1694 |
|
|
2021
Q3 | $45.1M | Sell |
1,959,963
-251,638
| -11% | -$5.79M | ﹤0.01% | 1452 |
|
|
2021
Q2 | $80.7M | Buy |
+2,211,601
| New | +$80.7M | 0.01% | 1213 |
|